0001209191-23-040269.txt : 20230630 0001209191-23-040269.hdr.sgml : 20230630 20230630143429 ACCESSION NUMBER: 0001209191-23-040269 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230630 DATE AS OF CHANGE: 20230630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sanders Corazon (Corsee) D. CENTRAL INDEX KEY: 0001796536 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36276 FILM NUMBER: 231061138 MAIL ADDRESS: STREET 1: C/O MOLECULAR TEMPLATES, INC. STREET 2: 9301 AMBERGLEN BLVD, SUITE 100 CITY: AUSTIN STATE: VI ZIP: 78729 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc. CENTRAL INDEX KEY: 0001515673 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272546083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 415-483-8800 MAIL ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-30 0 0001515673 Ultragenyx Pharmaceutical Inc. RARE 0001796536 Sanders Corazon (Corsee) D. C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949 1 0 0 0 0 Common Stock 2023-06-30 4 S 0 585 46.76 D 8985 D The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023. /s/ Karah Parschauer, attorney-in-fact 2023-06-30